CClinicalTrials.gg
Enrolling by invitationNCT06972797Updated May 15, 2025

Accuracy of 3D Slicer Software for Automatic Segmentation Versus Manual Segmentation Using Commercial Software to Evaluate Impacted and Unerupted Maxillary Canine: An Observational Study

An observational study in Impacted Canines, sponsored by Cairo University. Enrolling by invitation at 1 site in Egypt. Open to participants aged 8 Years to 70 Years. Per ClinicalTrials.gov, last updated 2025-05-15.

Sponsored by Cairo University · Observational

Study type
Observational
Model
Other
Time perspective
Retrospective
Enrollment
21
Ages
8 Years to 70 Years
Sex
All
01

Study summary

Our research question will be, can automatic segmentation of maxillary impacted and unerupted canine using DentalSegmentator tool in 3D silcer software be as accurate as manual segmentation?

02

Conditions studied

  • Impacted Canines

Browse trials for

03

Who can participate

Ages eligible
8 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

DICOM data will be collected from the data base anonymously

Inclusion criteria

Age ranges from 8-70y (from 8 to less than15y for unerupted group - from 15 to 70y for impacted group). b. Scans clearly showing unerupted and impacted maxillary canines.

Exclusion criteria

Exclusion Criteria:

  1. Scans with artifacts obscuring the area of interest.
  2. Scans with fractures or pathological lesions obscuring the area of interest.
  3. Image blurring due to patient movement during acquisition which could interfere with image interpretation.
04

Study design

Observational model
Other
Time perspective
Retrospective
Enrollment
21 participants (estimated)
Patient registry
No
05

What researchers measure

Primary outcomes

  1. 3D volume analysis

    Automatic segmentation of impacted canine and volumetric measurements

    Time frame: one year

06

Study locations

1 site
  • Cairo university- faculty of dentistry
    Cairo, القاهرة 12345, Egypt
07

Registry details

Key details

Study ID
NCT06972797
Lead sponsor
Cairo University
Responsible party
Rabab Amin (Assisstant lecturer, Cairo University) — Principal investigator
First posted
May 15, 2025
Start date
Sep 1, 2025 (estimated)
Primary completion
Sep 30, 2026 (estimated)
Completion
Oct 31, 2026 (estimated)
Last update
May 15, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion